Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use.

scientific article published on June 2013

Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ANNEPIDEM.2013.04.006
P8608Fatcat IDrelease_66ik7kcmrvcmrkder5xjif4kfi
P932PMC publication ID3718633
P698PubMed publication ID23683711

P50authorOliver W PressQ50211588
Sarah J. LowryQ57546360
Noel S. WeissQ88546264
P2093author name stringBarbara McKnight
Jessica Chubak
P2860cites workBinding of antidepressants to human brain receptors: focus on newer generation compoundsQ28307253
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatmentQ30458126
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).Q30479763
A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older womenQ33197092
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.Q33897785
A systematic review of antidepressants in neuropathic painQ34423548
Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristicsQ34583460
Immunosuppressive therapy and acquired immunological disordersQ35368828
H1-receptors: localization and role in airway physiology and in immune functionsQ35552822
Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control studyQ35572161
Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and studyQ36448975
Use of antidepressant medications in relation to the incidence of breast cancerQ36614001
Altered immunity as a risk factor for non-Hodgkin lymphomaQ36751495
Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004.Q36968563
Etiologic heterogeneity among non-Hodgkin lymphoma subtypesQ37003547
Population-based study of autoimmune conditions and the risk of specific lymphoid malignanciesQ37218079
Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohortQ37325965
Autoimmune and inflammatory disorders and risk of malignant lymphomas--an updateQ37328554
Tricyclic antidepressants and histamine H1 receptorsQ39270630
Lymphoma survival patterns by WHO subtype in the United States, 1973-2003.Q40110567
Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemiaQ43586262
Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.Q51838276
Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by SubtypeQ63353115
The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liverQ70195451
Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification ProjectQ77306442
Pediatric primary cutaneous marginal zone lymphoma: in association with chronic antihistamine useQ80262276
Antidepressant medication use and non-Hodgkin's lymphoma risk: no associationQ80537808
Tricyclic antidepressants and non-Hodgkin lymphomaQ81452545
Analysis of survival by tumor response and other comparisons of time-to-event by outcome variablesQ81798459
P433issue6
P921main subjectnon-Hodgkin lymphomaQ1138590
P304page(s)349-354
P577publication date2013-06-01
P1433published inAnnals of EpidemiologyQ4767848
P1476titleRisk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use.
P478volume23

Reverse relations

Q48682791Antidepressant use and risk of central nervous system metastasis.cites workP2860

Search more.